Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 5,44 MB, PDF-dokument

Unstable proteins are prone to form non-native interactions with other proteins and thereby may become toxic. To mitigate this, destabilized proteins are targeted by the protein quality control network. Here we present systematic studies of the cytosolic aspartoacylase, ASPA, where variants are linked to Canavan disease, a lethal neurological disorder. We determine the abundance of 6152 of the 6260 ( ~ 98%) possible single amino acid substitutions and nonsense ASPA variants in human cells. Most low abundance variants are degraded through the ubiquitin-proteasome pathway and become toxic upon prolonged expression. The data correlates with predicted changes in thermodynamic stability, evolutionary conservation, and separate disease-linked variants from benign variants. Mapping of degradation signals (degrons) shows that these are often buried and the C-terminal region functions as a degron. The data can be used to interpret Canavan disease variants and provide insight into the relationship between protein stability, degradation and cell fitness.
OriginalsprogEngelsk
Artikelnummer4026
TidsskriftNature Communications
Vol/bind15
Udgave nummer1
Antal sider18
ISSN2041-1723
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
We acknowledge the use of the FACS, sequencing,\u00A0microscopy, bioinformatics, and computing core facilities at the Biotech Research & Innovation Centre and the Department of Biology, University of Copenhagen. We thank Vibe H. Oestergaard, Michael Lisby, Leonor Rib, Nick Popp, Sofie V. Nielsen, S\u00F8ren Lindemose, and Anne-Marie Lauridsen for technical support. Figures\u00A01A, Fig.\u00A05B, Supplementary Fig.\u00A011C, created with BioRender.com, released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license. The work was funded by the Novo Nordisk Foundation (https://novonordiskfonden.dk) challenge program PRISM (to K.L.-L., A.S., D.M.F. & R.H.-P.), the Novo Nordisk Foundation NNF21OC0071057 (to R.H.P.), the Lundbeck Foundation (https://www.lundbeckfonden.com) R272-2017-452 and R209-2015-3283 (to A.S.), and R249-2017-510 (to L.C.), and the Danish Council for Independent Research (Det Frie Forskningsr\u00E5d) (https://dff.dk) https://doi.org/10.46540/2032-00007B (to R.H.P.).

Publisher Copyright:
© The Author(s) 2024.

ID: 392567884